AD Resemblance Atrophy Index as a Diagnostic Biomarker for Alzheimer's Disease: A Retrospective Clinical and Biological Validation

Journal of Alzheimer's Disease : JAD
Yingren MaiJun Liu

Abstract

Magnetic resonance imaging (MRI) provides objective information about brain structural atrophy in patients with Alzheimer's disease (AD). This multi-structural atrophic information, when integrated as a single differential index, has the potential to further elevate the accuracy of AD identification from normal control (NC) compared to the conventional structure volumetric index. We herein investigated the performance of such an MRI-derived AD index, AD-Resemblance Atrophy Index (AD-RAI), as a neuroimaging biomarker in clinical scenario. Fifty AD patients (19 with the Amyloid, Tau, Neurodegeneration (ATN) results assessed in cerebrospinal fluid) and 50 age- and gender-matched NC (19 with ATN results assessed using positron emission tomography) were recruited in this study. MRI-based imaging biomarkers, i.e., AD-RAI, were quantified using AccuBrain®. The accuracy, sensitivity, specificity, and area under the ROC curve (AUC) of these MRI-based imaging biomarkers were evaluated with the diagnosis result according to clinical criteria for all subjects and ATN biological markers for the subgroup. In the whole groups of AD and NC subjects, the accuracy of AD-RAI was 91%, sensitivity and specificity were 88% and 96%, respectively, and...Continue Reading

References

Apr 10, 1992·Science·J A Hardy, G A Higgins
Mar 5, 2011·Lancet·Clive BallardEmma Jones
Dec 3, 2011·Science Translational Medicine·Reisa SperlingPaul S Aisen
Jan 12, 2012·Journal of Alzheimer's Disease : JAD·Nicolás FayedJosé Gazulla
Dec 1, 2015·PloS One·Min Soo ByunAlzheimer’s Disease Neuroimaging Initiative
Jan 27, 2016·Ageing Research Reviews·Hiroshi Matsuda
Feb 28, 2016·Lancet·Philip ScheltensWiesje M van der Flier
Mar 5, 2016·Brain : a Journal of Neurology·Lorna HarperJonathan M Schott
Mar 7, 2017·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Paolo BoscoGiovanni B Frisoni
Mar 9, 2017·Journal of Alzheimer's Disease : JAD·Francis T HaneMitchell S Albert
Oct 19, 2017·Journal of Alzheimer's Disease : JAD·Bruno Dubois
Feb 20, 2018·Neurobiology of Aging·Konstantinos PoulakisEric Westman
Apr 15, 2018·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Clifford R JackContributors
Jul 27, 2018·Nature·Richard Hodson
Nov 8, 2018·Journal of Alzheimer's Disease : JAD·Monia CabinioMario Clerici
Jan 1, 2020·Brain : a Journal of Neurology·AmanPreet BadhwarPierre Bellec

Related Concepts

Alzheimer's Disease
Amyloid
Biological Markers
Brain
Cerebrospinal Fluid
Classification
Diagnosis
Magnetic Resonance Imaging
Nerve Degeneration
Positron-Emission Tomography

Related Feeds

Alzheimer's Disease: Neuroimaging

Neuroimaging can help identify pathological hallmarks of Alzheimer's disease (AD). Here is the latest research on neuroimaging modalities, including magnetic resonance imaging and positron emission tomography, in AD.

CSF & Lymphatic System

This feed focuses on Cerebral Spinal Fluid (CSF) and the lymphatic system. Discover the latest papers using imaging techniques to track CSF outflow into the lymphatic system in animal models.

Alzheimer's Disease: Tau & TDP-43

Alzheimer's disease is a neurodegenerative disease. This feed focuses on the underlying role of tau proteins and TAR DNA-binding protein 43, as well as other genetic factors, in Alzheimer's disease.